TY  - GEN
AU  - Hackelsberger,A
AU  - Malfertheiner,P
TI  - A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection
SN  - 0114-5916
PY  - 1997///0121
KW  - Amoxicillin
KW  - administration & dosage
KW  - Anti-Bacterial Agents
KW  - therapeutic use
KW  - Bismuth
KW  - Clarithromycin
KW  - Drug Therapy, Combination
KW  - Dyspepsia
KW  - microbiology
KW  - Helicobacter Infections
KW  - drug therapy
KW  - Helicobacter pylori
KW  - drug effects
KW  - Histamine H2 Antagonists
KW  - Humans
KW  - Nitroimidazoles
KW  - Omeprazole
KW  - Penicillins
KW  - Peptic Ulcer
KW  - Proton Pump Inhibitors
KW  - Risk Assessment
KW  - Tetracyclines
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.2165/00002018-199615010-00003
ER  -